Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial.
Frank MJ, Khodadoust MS, Czerwinski DK, Haabeth OAW, Chu MP, Miklos DB, Advani RH, Alizadeh AA, Gupta NK, Maeda LS, Reddy SA, Laport GG, Meyer EH, Negrin RS, Rezvani AR, Weng WK, Sheehan K, Faham M, Okada A, Moore AH, Phillips DL, Wapnir IL, Brody JD, Levy R.
Frank MJ, et al. Among authors: gupta nk.
J Exp Med. 2020 Sep 7;217(9):e20191712. doi: 10.1084/jem.20191712.
J Exp Med. 2020.
PMID: 32558897
Free PMC article.
Clinical Trial.